Interim 2023/24 season influenza vaccine effectiveness in primary and secondary care in the United Kingdom
Whitaker, H.; Findlay, B.; Zitha, J.; Goudie, R.; Hassell, K.; Evans, J.; Kalapotharakou, P.; Agrawal, U.; Kele, B.; Hamilton, M.; Moore, C.; Byford, R.; Stowe, J.; Robertson, C.; Couzens, A.; Jamie, G.; Hoschler, K.; Pheasant, K.; Button, E.; Quinot, C.; Jones, T.; Anand, S.; Watson, C.; Andrews, N.; de Lusignan, S.; Zambon, M.; Williams, C.; Cottrell, S.; Marsh, K.; McMenamin, J.; Lopez-Bernal, J.
Show abstract
We report 2023/24 season interim influenza vaccine effectiveness for three studies, including primary care in Great Britain, hospital settings in Scotland and hospital settings in England. Adjusted vaccine effectiveness against all influenzas ranged from 63% (46 to 75%) to 65% (41 to 79%) among children aged 2-17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18-64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults 94%
- Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales 93%
- Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 93%
Similar papers in this journal
- Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection? 95%
- Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine 94%
- The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: influenza incidence, seasonality, and transmission 94%
Similar papers in this journal
- Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: A multi-country analysis 92%
- Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY 92%
- Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-Based Case-Control Study in St. Petersburg, Russia 91%
Similar papers in this journal
- Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK 92%
- Sociodemographic inequality in COVID-19 vaccination coverage amongst elderly adults in England: a national linked data study 92%
- Reports of myocarditis and pericarditis following mRNA COVID-19 vaccines: A systematic review of spontaneously reported data from the UK, Europe, and the US and of the literature 92%
Similar papers in this journal
- Estimates of epidemiological parameters for H5N1 influenza in humans: a rapid review 93%
- The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021-2022 92%
- Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.